[REGN] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
15-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- 145.68%
YoY- 980.20%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 1,098,077 802,329 610,412 414,602 122,977 133,675 96,800 49.86%
PBT 227,289 221,287 198,153 134,559 -54,058 -14,597 -40,611 -
Tax 72,295 111,111 101,347 -335,848 -615 846 -4,122 -
NP 154,994 110,176 96,806 470,407 -53,443 -14,597 -36,489 -
Tax Rate -31.81% -50.21% -51.15% 249.59% - - - -
Total Cost 943,083 692,153 513,606 -55,805 176,420 148,272 133,289 38.53%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 14.12 13.73 15.86 113.46 -43.46 -10.92 -37.70 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS 1.49 0.89 0.98 4.92 -0.58 -0.17 -0.46 -
EPS Diluted 1.34 0.79 0.73 4.26 -0.57 -0.17 -0.45 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.